着床前遺伝子診断(PGD)の世界市場2019-2023

LINEで送る

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Fertility clinics and maternity centers – Market size and forecast 2018-2023
• Hospitals and diagnostic laboratories – Market size and forecast 2018-2023
• Research institutes – Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Advances in genetic sequencing technologies
• Rising adoption of online testing kits and services
• Growing demand for non-invasive biopsy procedures in PGD
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Genea Ltd.
• Igenomix Sl
• Illumina Inc.
• Invitae Corp.
• Laboratory Corp. of America Holdings
• Natera Inc.
• Oxford Gene Technology Group
• PerkinElmer Inc.
• Quest Diagnostics Inc.
• Thermo Fisher Scientific Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO

Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: End-user – Market share 2018-2023 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Fertility clinics and maternity centers – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Fertility clinics and maternity centers – Year-over-year growth 2019-2023 (%)
Exhibit 22: Hospitals and diagnostic laboratories – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Hospitals and diagnostic laboratories – Year-over-year growth 2019-2023 (%)
Exhibit 24: Research institutes – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Research institutes – Year-over-year growth 2019-2023 (%)
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Genea Ltd. – Vendor overview
Exhibit 46: Genea Ltd. – Business segments
Exhibit 47: Genea Ltd. – Organizational developments
Exhibit 48: Genea Ltd. – Key offerings
Exhibit 49: Igenomix Sl – Vendor overview
Exhibit 50: Igenomix Sl – Business segments
Exhibit 51: Igenomix Sl – Organizational developments
Exhibit 52: Igenomix Sl – Key offerings
Exhibit 53: Illumina Inc. – Vendor overview
Exhibit 54: Illumina Inc. – Business segments
Exhibit 55: Illumina Inc. – Organizational developments
Exhibit 56: Illumina Inc. – Geographic focus
Exhibit 57: Illumina Inc. – Segment focus
Exhibit 58: Illumina Inc. – Key offerings
Exhibit 59: Invitae Corp. – Vendor overview
Exhibit 60: Invitae Corp. – Business segments
Exhibit 61: Invitae Corp. – Organizational developments
Exhibit 62: Invitae Corp. – Geographic focus
Exhibit 63: Invitae Corp. – Key offerings
Exhibit 64: Laboratory Corp. of America Holdings – Vendor overview
Exhibit 65: Laboratory Corp. of America Holdings – Business segments
Exhibit 66: Laboratory Corp. of America Holdings – Organizational developments
Exhibit 67: Laboratory Corp. of America Holdings – Geographic focus
Exhibit 68: Laboratory Corp. of America Holdings – Segment focus
Exhibit 69: Laboratory Corp. of America Holdings – Key offerings
Exhibit 70: Natera Inc. – Vendor overview
Exhibit 71: Natera Inc. – Business segments
Exhibit 72: Natera Inc. – Organizational developments
Exhibit 73: Natera Inc. – Geographic focus
Exhibit 74: Natera Inc. – Key offerings
Exhibit 75: Oxford Gene Technology Group – Vendor overview
Exhibit 76: Oxford Gene Technology Group – Business segments
Exhibit 77: Oxford Gene Technology Group – Organizational developments
Exhibit 78: Oxford Gene Technology Group – Key offerings
Exhibit 79: PerkinElmer Inc. – Vendor overview
Exhibit 80: PerkinElmer Inc. – Business segments
Exhibit 81: PerkinElmer Inc. – Organizational developments
Exhibit 82: PerkinElmer Inc. – Geographic focus
Exhibit 83: PerkinElmer Inc. – Segment focus
Exhibit 84: PerkinElmer Inc. – Key offerings
Exhibit 85: Quest Diagnostics Inc. – Vendor overview
Exhibit 86: Quest Diagnostics Inc. – Business segments
Exhibit 87: Quest Diagnostics Inc. – Organizational developments
Exhibit 88: Quest Diagnostics Inc. – Segment focus
Exhibit 89: Quest Diagnostics Inc. – Key offerings
Exhibit 90: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 91: Thermo Fisher Scientific Inc. – Business segments
Exhibit 92: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 93: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 94: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 95: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 96: Validation techniques employed for market sizing
Exhibit 97: Definition of market positioning of vendors




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様